소아 진정 치료 시 구강 점막 하와 비점막 Midazolam 투여의 행동 반응 비교
Comparison of behavioral response between intranasal and submucosal midazolam adminstration
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose. The objective of this study was to evaluate the behavioral response and assess the effectiveness of additional intranasal (IN) and submucosal (SM) administration of midazolam during pediatric sedation for dental procedure. Material and methods. Thirty-three cases of healthy (ASAⅠ), uncooperative children aged from 24 to 72 month old at pediatric dental clinic of Ewha Womans University Hospital were selected for this study. Children received oral chloral hydrate 50 mg/kg with hydroxyzine 1.0 mg/kg. After waiting for 45 minutes, midazolam 0.2 mg/kg was administrated via IN route and via SM route randomly maintaining 50% of N2O. A pulse oximeter and a capnograph were used for measuring vital signs (SpO2, PR, RR, EtCO2) throughout the sedation. Behavioral response was evaluated as Quiet (Q), Crying (C), Movement (M) or Struggling (S) in every 2 minutes for 40 minutes. Results. There were also no statistically significant differences in vital signs of the two groups. The behavioral response for the first ten minutes during sedation was a statistically significant difference (P < 0.05) between the two groups. After the first ten minutes, it was revealed that there was no significant difference. Conclusion. This study demonstrated that the addition of IN midazolam to the combination of oral chloral hydrate with hydroxyzine and nitrous oxide/oxygen inhalation is as safe and effective as that of SM midazolam in pediatric sedation for dental procedure.
Abstract
Purpose. The objective of this study was to evaluate the behavioral response and assess the effectiveness of additional intranasal (IN) and submucosal (SM) administration of midazolam during pediatric sedation for dental procedure. Material and methods. Thirty-three cases of healthy (ASAⅠ), uncooperative children aged from 24 to 72 month old at pediatric dental clinic of Ewha Womans University Hospital were selected for this study. Children received oral chloral hydrate 50 mg/kg with hydroxyzine 1.0 mg/kg. After waiting for 45 minutes, midazolam 0.2 mg/kg was administrated via IN route and via SM route randomly maintaining 50% of N2O. A pulse oximeter and a capnograph were used for measuring vital signs (SpO2, PR, RR, EtCO2) throughout the sedation. Behavioral response was evaluated as Quiet (Q), Crying (C), Movement (M) or Struggling (S) in every 2 minutes for 40 minutes. Results. There were also no statistically significant differences in vital signs of the two groups. The behavioral response for the first ten minutes during sedation was a statistically significant difference (P < 0.05) between the two groups. After the first ten minutes, it was revealed that there was no significant difference. Conclusion. This study demonstrated that the addition of IN midazolam to the combination of oral chloral hydrate with hydroxyzine and nitrous oxide/oxygen inhalation is as safe and effective as that of SM midazolam in pediatric sedation for dental procedure.
참고문헌 (39)
- Nathan JE, "Comparison of chloral hydrate- hydroxyzine with and without meperidine for management of the difficult pediatric patient", ASDC J Dent Child, 54, pp.437~444 (1987)
- Wilson S, "A retrospective study of chloral hydrate, meperidine, hydroxyzine, and midazolam regimens used to se date children for dental care", Pediatr Dent, 22, pp.107~112 (2000)
- Dallman JA, "Comparing the safety, efficacy and recovery of intranasal midazolam vs. oral chloral hydrate and promethazine", Pediatr Dent, 23, pp.424~430 (2001)
- Primosch RE, "Factors associated with administration route when using midazolam for pediatric conscious sedation", ASDC J Dent Child, 68, pp.233~238 (2001)
- Needleman HL, "Conscious sedation of pediatric dental patients using chloral hydrate, hydroxyzine, and nitrous oxide-a retrospective study of 382 sedations", Pediatr Dent, 17, pp.424~431 (1995)
- Nathan JE, "Management of the difficult child: a survey of pediatric dentists' use of restraints, sedation and general anesthesia", ASDC J Dent Child, 56, pp.293~301 (1989)
- Houpt M, "Project USAP 2000-use of sedative agents by pediatric dentists: a 15-year follow-up survey", Pediatr Dent, 24, pp.289~294 (2002)
- Moore PA, "Therapeutic assessment of chloral hydrate premedication for pediatric dentistry", Anesth Prog, 31, pp.191~196 (1984)
- Kupietzky A, "Midazolam : a review of its use for conscious sedation of children", Pediatr Dent, 15, pp.237~241 (1993)
- Kupietzky A, "Intranasal midazolam better at effecting amnesia after sedation than oral hydroxyzine: a pilot study", Pediatr Dent, 18, pp.32~34 (1996)
- Wilton NC, "Preanesthetic sedation of preschool children using intranasal midazolam. Anesthesiology,69:972-5, 1998.12. Hartgraves PM, Primosch RE : An evaluation of oral and nasal midazolam for pediatric dental sedation", ASDC J Dent Child, 61, pp.175~181 (1994)
- Hartgraves PM, "An evaluation of oral and nasal midazolam for pediatric dental sedation", ASDC J Dent Child, 61, pp.175~181 (1994)
- Fuks AB, "Assessment of two doses of intranasal midazolam", Pediatr Dent, 16, pp.301~305 (1994)
- Myers GR, "Effect of submucosal midazolam on behavior and physiologic response when combined with oral chloral hydrate and nitrous oxide sedation", Pediatr Dent, 26, pp.37~43 (2004)
- 백광우, "소아 진정 시 구강 협점막하로 투여한 Midazolam의 효과에 관한 연구", 대한치과마취과학회지, 5(2), pp.101~106 (2005), 대한치과마취과학회
- 이영은, "점막하 Midazolam의 병용투여 시 BIS 분석을 이용한 진정 평가", 대한소아치과학회지, 34(1), pp.91~98 (2007), 대한소아치과학회
- 김경희, "소아환자의 진정요법 효과와 그와 연관된 변수에 대한 연구", 대한소아치과학회지, 34(2), pp.234~246 (2007), 대한소아치과학회
- De Boer AG, "Drug absorption by sublingual and rectal routes", Br J Anaesth, 56, pp.69~82 (1984)
- Hussain AA, "Mechanism of nasal absorption of drugs", Prog Clin Biol Res, 292, pp.261~272 (1989)
- Walbergh EJ, "Plasma concentrations of midazolam in children following intranasal administration", Anesthesiology, 74, pp.233~235 (1991)
- Schwagmeier R, "Midazolam pharmacokinetics following intravenous and buccal administration", Br J Clin Pharmacol, 46, pp.203~206 (1998)
- Sayany Z, "Plasma levels of intranasal midazolam at 0.4 mg", kg and 0.2 mg, Pediatr Dent, pp.1996, 18[DOI]
- Caudill WA, "Absorption rates of alphaprodine from the buccal and intravenous routes", Pediatr Dent, 4, pp.168~170 (1982)
- Flankl SN, "Should the parent remain in the operatory?", J Dent Child, 29, pp.150~163 (1962)
- American Academy of Pediatric Dentistry, "Guideline on the elective use of minimal, moderate, and deep sedation and general anesthesia for pediatric dental patients", Pediatr Dent, 27, pp.110~118 (2005)
- MacDonald RE AD, "Dentistry for the child and adolescent. 8th Ed", pp.292~ (2003), Mosby
- Malviya S, "Adverse events and risk factors associated with the sedation of children by nonanesthesiologists", Anesth Analg, 85, pp.1207~1213 (1997)
- Cote CJ, "Adverse sedation events in pediatrics: analysis of medications used for sedation", Pediatrics, 106, pp.633~644 (2000)
- Moody EH Jr, "The therapeutic effectiveness of nitrous oxide and chloral hydrate administered orally, rectally, and combined with hydroxyzine for pediatric dentistry", ASDC J Dent Child, 53, pp.425~429 (1986)
- Chen JW, "Assessment of the effects of 2 sedation regimens on cardiopulmonary parameters in pediatric dental patients: a retrospective study", Pediatr Dent, 28, pp.350~356 (2006)
- Alfonzo-Echeverri E, "Absorption and elimination of midazolam by submucosal and intramuscular routes", Anesth Prog, 37, pp.277~281 (1990)
- Fukuta O, "Intranasal administration of midazolam: pharmacokinetic and pharmacodynamic properties and sedative potential", ASDC J Dent Child, 64, pp.89~98 (1997)
- Primosch RE, "Comparison of drops versus spray administration of intranasal midazolam in two- and three-year-old children for dental sedation", Pediatr Dent, 27, pp.401~408 (2005)
- Karl HW, "Transmucosal administration of midazolam for premedication of pediatric patients. Comparison of the nasal and sublingual routes", Anesthesiology, 78, pp.885~891 (1993)
- Lee-Kim SJ, "Nasal versus oral midazolam sedation for pediatric dental patients", J Dent Child (Chic), 71, pp.126~130 (2004)
- Abernethy DR, "Drug disposition in obese humans", Clin Pharmacokinet, 11, pp.199~213 (1986)
- Blouin RA, "Influence of obesity on drug disposition", Clin Pharm, 6, pp.706~714 (1987)
- Baker S, "Obesity : a complicating factor for sedation in children", Pediatr Dent, 28, pp.487~493 (2006)
- 백광우, "The Comparison of Behavioral Response of Additional Submucosal Midazolam with Oral Chloral Hydrate,Hydroxyzine and Nitrous Oxide for Pediatric Conscious Sedation", 대한치과마취과학회지, 7(1), pp.6~12 (2007), 대한치과마취과학회
